Topical niacinamide and barrier enhancement.
Bissett
Donald
D
Procter & Gamble Company, Cincinnati, Ohio, USA.
D000279:Administration, Cutaneous; D002986:Clinical Trials as Topic; D004817:Epidermis / Q000187:drug effects / Q000502:physiology*; D005148:Facial Dermatoses / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage*; D009536:Niacinamide / Q000008:administration & dosage*; D015595:Skin Aging
D007641:Keratolytic Agents; D009536:Niacinamide